Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose:Recent studies have demonstrated that resveratrol (RSV) reduces the incidence of age-related macular degeneration, Alzheimer’s disease (AD), and stroke, while melatonin (MEL) supplementation reduces the progression of the cognitive impairment in AD patients. The purpose of this investigation was to assess whether the co-administration of MEL and RSV exerts synergistic effects on their neuroprotective properties against β-amyloid (Aβ)-induced neuronal death. Methods: The neuroprotective effects of co-treatment with MEL and RSV on Aβ1-42 -induced cell death, was measured by MTT reduction assay. Aβ1-42 caused an increase in intracellular levels of reactive oxygen species (ROS), as assessed by H2 -DCF-DA dye, and a reduction of total glutathione (GSH) levels and mitochondrial membrane potential, as assessed using monochlorobimane and rhodamine 123 fluorescence, respectively. Western blotting was used to investigate the intracellular signaling mechanism involved in these synergic effects. Results: We treated a murine HT22 hippocampal cell line with MEL or RSV alone or with both simultaneously. MEL and RSV alone significantly attenuated ROS production, mitochondrial membrane-potential disruption and the neurotoxicity induced by Aβ1-42. They also restored the Aβ1-42-induced depletion of GSH, back to within its normal range and prevented the Aβ1-42-induced activation of glycogen synthase kinase 3β(GSK3β). However, co-treatment with MEL and RSV did not exert any significant synergistic effects on either the recovery of the Aβ1-42-induced depletion of GSH or on the inhibition of Aβ1-42-induced GSK3βactivation. Aβ1-42 treatment increased AMP-activated protein kinase (AMPK) activity, which is associated with subsequent neuronal death. We demonstrated that MEL and RSV treatment inhibited the phosphorylation of AMPK. Conclusions: Together, our results suggest that co-administration of MEL and RSV acts as an effective treatment for AD by attenuating Aβ1-42-induced oxidative stress and the AMPK-dependent pathway.
Abstract
Background and Purpose:Recent studies have demonstrated that resveratrol (RSV) reduces the incidence of age-related macular degeneration, Alzheimer’s disease (AD), and stroke, while melatonin (MEL) supplementation reduces the progression of the cognitive impairment in AD patients. The purpose of this investigation was to assess whether the co-administration of MEL and RSV exerts synergistic effects on their neuroprotective properties against β-amyloid (Aβ)-induced neuronal death. Methods: The neuroprotective effects of co-treatment with MEL and RSV on Aβ1-42 -induced cell death, was measured by MTT reduction assay. Aβ1-42 caused an increase in intracellular levels of reactive oxygen species (ROS), as assessed by H2 -DCF-DA dye, and a reduction of total glutathione (GSH) levels and mitochondrial membrane potential, as assessed using monochlorobimane and rhodamine 123 fluorescence, respectively. Western blotting was used to investigate the intracellular signaling mechanism involved in these synergic effects. Results: We treated a murine HT22 hippocampal cell line with MEL or RSV alone or with both simultaneously. MEL and RSV alone significantly attenuated ROS production, mitochondrial membrane-potential disruption and the neurotoxicity induced by Aβ1-42. They also restored the Aβ1-42-induced depletion of GSH, back to within its normal range and prevented the Aβ1-42-induced activation of glycogen synthase kinase 3β(GSK3β). However, co-treatment with MEL and RSV did not exert any significant synergistic effects on either the recovery of the Aβ1-42-induced depletion of GSH or on the inhibition of Aβ1-42-induced GSK3βactivation. Aβ1-42 treatment increased AMP-activated protein kinase (AMPK) activity, which is associated with subsequent neuronal death. We demonstrated that MEL and RSV treatment inhibited the phosphorylation of AMPK. Conclusions: Together, our results suggest that co-administration of MEL and RSV acts as an effective treatment for AD by attenuating Aβ1-42-induced oxidative stress and the AMPK-dependent pathway.
참고문헌 (33)
- Kelley BJ, "Alzheimer’s disease and mild cognitive impairment", Neurol Clin, 25, pp.577~609 (2007)
- Selkoe DJ, "The molecular pathology of Alzhiemer’s disease", Neuron, 6, pp.487~498 (1991)
- Bhat RV, "Glycogen synthase kinase 3:a drug target for CNS therapies", J Neurochem, 89, pp.1313~1317 (2004)
- Williams KW, ""AMPing up"our understanding of the hypothalamic control of energy balance", J Clin Invest, 117, pp.2089~2092 (2007)
- Reiter RJ, "Pineal melatonin:cell biology of its synthesis and of its physiological interactions", Endocr Rev, 12, pp.151~180 (1991)
- Witt-Enderby PA, "Therapeutic treatments potentially mediated by melatonin receptors:potential clinical uses in the prevention of osteoporosis,cancer and as an adjuvant therapy", J Pineal Res, 41, pp.297~305 (2006)
- Reiter RJ, "Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo", Biol Signals Recept, 9, pp.160~171 (2000)
- Antolín I, "Protective effect of melatonin in a chronic experimental model of Parkinson’s disease", Brain Res, 943, pp.163~173 (2002)
- Shen YX, "Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25-35", J Pineal Res, 32, pp.163~167 (2002)
- Costa EJ, "Permeability of pure lipid bilayers to melatonin", J Pineal Res, 19, pp.123~126 (1995)
- Pierpaoli W, "Pineal control of aging:effect of melatonin and pineal grafting on aging mice", Proc Natl Acad Sci U S A, 91, pp.787~791 (1994)
- Reiter RJ, "Melatonin in the context of the free radical theory of aging", Ann N Y Acad Sci, 786, pp.362~378 (1996)
- Reiter RJ, "A review of the evidence supporting melatonin’s role as an antioxidant", J Pineal Res, 18, pp.1~11 (1995)
- Baur JA, "Therapeutic potential of resveratrol:the in vivo evidence", Nat Rev Drug Discov, 5, pp.493~506 (2006)
- Zhuang H, "Potential mechanism by which resveratrol,a red wine constituent,protects neurons", Ann N Y Acad Sci, 993, pp.276~286 (2003)
- Gao D, "Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice", Life Sci, 78, pp.2564~2570 (2006)
- Okawara M, "Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults", Biochem Pharmacol, 73, pp.550~560 (2007)
- Marambaud P, "Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides", J Biol Chem, 280, pp.37377~37382 (2005)
- Valenzano DR, "Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate", Curr Biol, 16, pp.296~300 (2006)
- Baur JA, "Therapeutic potential of resveratrol:the in vivo evidence", Nat Rev Drug Discov, 5, pp.493~506 (2006)
- 한설희, "Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases", Journal of Clinical Neurology, 5(3), pp.120~125 (2009), 대한신경과학회
- Baur JA, "Resveratrol improves health and survival of mice on a high-calorie diet", Nature, 444, pp.337~342 (2006)
- Mook-Jung I, "Estrogen blocks neurotoxic effects of beta-amyloid(1-42)and induces neurite extension on B103 cells", Neurosci Lett, 235, pp.101~104 (1997)
- LeBel CP, "Organometal-induced increases in oxygen reactive species:the potential of 2',7'-dichlorofluorescin diacetate as an index of neurotoxic damage", Toxicol Appl Pharmacol, 104, pp.17~24 (1990)
- Martín M, "Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria", Int J Biochem Cell Biol, 34, pp.348~357 (2002)
- Lagouge M, "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha", Cell, 127, pp.1109~1122 (2006)
- BALANCE investigators and collaborators, "Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder(BALANCE):a randomised open-label trial", Lancet, 375, pp.385~395 (2010)
- Tajes M, "Anti-aging properties of melatonin in an in vitro murine senescence model:involvement of the sirtuin 1 pathway", J Pineal Res, 47, pp.228~237 (2009)
- Chong YH, "ERK-1", 2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures, 2006, pp.281, 20315~20325
- Lee EO, "Resveratrol reduces glutamate-mediated monocyte chemotactic protein-1 expression via inhibition of extracellular signal-regulated kinase 1", 2 pathway in rat hippocampal slice cultures, 2010, pp.112, 1477~1487
- Vingtdeux V, "AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism", J Biol Chem, 285, pp.9100~9133 (2010)
- Ha E, "Melatonin stimulates glucose transport via insulin receptor substrate-1", phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells, 2006, pp.41, 67~72
- Kim SD, "Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1", 2 activation and tr-anslocation of NF-kappaB in rat primary astrocyte, 2007, pp.1186, 12~20